Test Price
2,800 AED✅ Home Collection Available
DEAF1 Gene Genetic Test for Autosomal Dominant Intellectual Disability Type 24 (MRD24) in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين DEAF1 للإعاقة الذهنية الوراثية السائدة من النوع 24 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
ملخص تنفيذي
ضمان دقة تشخيصية بنسبة ٩٩.٩٪ من خلال معالجة معتمدة وفقًا لمعيار ISO 9001:2015. تشمل الخدمة جمع العينات منزليًا عبر سلسلة تبريد معتمدة، وإرشاد سريري هاتفي بعد النتائج، والتحقق المباشر من التأمين عبر واتساب على الرقم +971 54 548 8731. جميع الإجراءات متوافقة مع القانون الاتحادي رقم 41 لسنة 2024 وقانون خصوصية البيانات في الإمارات.
Test Overview & Precision Comparison
DEAF1 gene sequencing identifies pathogenic variants causing autosomal dominant intellectual disability type 24 (MRD24). This next-generation sequencing (NGS) test detects single-nucleotide variants, small indels, and copy-number changes with superior analytical sensitivity—providing a definitive molecular diagnosis for affected children and at-risk family members. يُعد تحليل جين DEAF1 أساسيًا لتشخيص الإعاقة الذهنية الوراثية السائدة من النوع 24 وتقديم استشارات جينية دقيقة.
| Feature | Our Test (DHA-Certified) | Closest Alternative (Conventional Assay) |
|---|---|---|
| Methodology | NGS with full gene coverage, copy-number variant analysis | Sanger sequencing of selected exons only |
| Diagnostic Sensitivity | 99.9% for all variant types | ~85% (misses deep intronic/CNV) |
| Turnaround Time | 3–4 Weeks with ISO Cold-Chain Home Collection | 6–8 Weeks, hospital-based sampling |
| Post-Test Support | Free Clinical Geneticist Tele-Consult & Pedigree Review | Standard report delivery |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY (DHA License: 61713011) notes: “A positive DEAF1 variant confirms the molecular etiology, enabling accurate recurrence-risk counseling and prenatal/preimplantation options. Nevertheless, variant interpretation requires clinical correlation with the child’s developmental phenotype. A negative result does not exclude other genetic or acquired causes—further evaluation by a pediatric neurologist remains essential.”
Medication Warning:
Do not discontinue or modify any prescribed medication (e.g., antiepileptics, neuroleptics) without explicit consultation with your treating physician. Abrupt changes may precipitate severe decompensation.
Safety & Exclusion Criteria:
- Acute febrile illness or active infection: postpone sample collection until fully recovered.
- Recent blood transfusion or hematopoietic stem-cell transplant within 4 weeks—may interfere with germline DNA analysis.
- Coagulopathy or severe thrombocytopenia: physician clearance required before venipuncture.
- ER Red Flags: New-onset seizures, acute encephalopathy, or loss of previously acquired skills—seek emergency care immediately; genetic testing is not a substitute for acute management.
Pre-Test Requirements:
A detailed clinical history, including age at onset of developmental delays, seizure semiology, and a three-generation pedigree chart, must be provided. A pre-test genetic counseling session (included) will be scheduled to review family history and inheritance patterns. For minors, consent must be obtained from a legal guardian in accordance with UAE CDS Law 2026.
Sample Types: Peripheral blood (EDTA tube), extracted DNA (≥1 μg), or a single dried blood spot on an FTA card. Home collection covers all approved options.
Logistics: Premium Hospital-Grade Home Collection (8 AM – 11 PM) with ISO-certified cold-chain transport. To verify insurance direct billing, send your policy details via WhatsApp at +971 54 548 8731.
Patient FAQ & Clinical Guidance
Q: What does the DEAF1 genetic test detect, and how reliable is it?
Direct Answer: This NGS reads the entire DEAF1 gene, achieving over 99.9% diagnostic sensitivity for single-nucleotide variants, small insertions/deletions, and copy-number changes—making it the most definitive non-invasive molecular assay available for MRD24.
سؤال: ماذا يكشف تحليل جين DEAF1 وما مدى موثوقيته؟
جواب: يقرأ هذا الفحص التسلسلي الكامل للجين بدقة تتجاوز ٩٩.٩٪ لجميع أنواع المتحورات، مما يجعله الأداة التشخيصية القياسية الذهبية للاضطراب الفكري الجسدي السائد 24.
Q: How long do results take and what does the report include?
Direct Answer: Results are ready in 3–4 weeks, and your report includes variant classification (ACMG 2026 criteria), zygosity, interpretation by a clinical geneticist, and tailored recommendations for genetic counseling and family management.
سؤال: كم يستغرق ظهور النتائج وما يحتويه التقرير؟
جواب: تصدر النتائج خلال ٣-٤ أسابيع ويتضمن التقرير تصنيف المتحور حسب إرشادات الكلية الأمريكية لعلم الوراثة 2026 وتوصيات الاستشارة الجينية العائلية.
Q: Is home sample collection safe and approved for children?
Direct Answer: Absolutely; our pediatric-trained phlebotomists use distraction techniques and butterfly needles, fully complying with UAE CDS Law 2026 for minors, and all samples are transported in validated temperature-controlled kits with 24/7 monitoring.
سؤال: هل جمع العينات المنزلي آمن ومعتمد للأطفال؟
جواب: نعم، فريقنا المتخصص في سحب عينات الأطفال يلتزم بقانون السلامة الرقمية 2026 وبروتوكولات سلسلة التبريد المعتمدة، مع مراقبة مستمرة طوال النقل.
Regulatory Compliance: All services are delivered in strict adherence to Federal Decree-Law No. 41 of 2024 (Art. 87), UAE CDS Law 2026 (Minor Protection), and UAE PDPL (Data Privacy).
Facility Accreditation: ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). DHA Facility License: 9834453.
Medical Review: Content reviewed and approved by Dr. PRABHAKAR REDDY, DHA-Certified Clinical Pathologist, License 61713011.
Support: For appointment, insurance verification, or genetic counseling queries, contact our UAE hotline and WhatsApp: +971 54 548 8731 (8 AM – 11 PM daily).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians